Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Novo Nordisk has made its smart insulin pens available in the UK ... The Danish pharma is trying to stay ahead of arch rivals Eli Lilly and Sanofi in an increasingly competitive insulin market ...

After years of preparation, Eli Lilly is on the brink of launching ... developing an add-on device for its existing pen range. Smart insulin pens are expected to drive the insulin pen market ...

Key players in the insulin pens, syringes, pumps and injectors market include Novo Nordisk A/S, Eli Lilly and Company, Medtronic plc, Abbott Laboratories, Insulet Corporation, Sanofi Aventis ...

"I thought: No insulin? Death is imminent," Wright said. Three drug companies dominate the U.S. insulin market: Novo Nordisk, Eli Lilly and Sanofi ... 800 million insulin pens a year.

At the end of August, Eli Lilly announced it would sell single-use vials of Zepbound directly to patients at a significantly lower price than its injection pens. Affordability is Galindo's top ...

If you’re on the fence about investing in Eli Lilly and Company or Novo ... The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

This all-encompassing guide investigates the smart insulin pen and its influence on diabetes management. Here's what you need ...